Stock Mover of the Day: Applied Dna Sciences Inc (NASDAQ:APDN) Institutional Investors Sentiment

November 18, 2016 - By kentuckypostne   ·   0 Comments

Stock Mover of the Day: Applied Dna Sciences Inc (NASDAQ:APDN) Institutional Investors Sentiment

Sentiment for Applied Dna Sciences Inc (NASDAQ:APDN)

Applied Dna Sciences Inc (NASDAQ:APDN) institutional sentiment decreased to 1 in 2016 Q2. Its down -0.44, from 1.44 in 2016Q1. The ratio dropped, as 13 investment professionals increased and opened new holdings, while 9 decreased and sold their equity positions in Applied Dna Sciences Inc. The investment professionals in our partner’s database reported: 1.65 million shares, down from 1.68 million shares in 2016Q1. Also, the number of investment professionals holding Applied Dna Sciences Inc in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 7 Reduced: 2 Increased: 9 New Position: 4.

Applied DNA Sciences, Inc. provides plant deoxyribonucleic acid security, and authentication solutions and services that help protect products, brands, supply chains and intellectual property of companies, governments and clients from theft, counterfeiting, fraud and diversion. The company has a market cap of $57.79 million. The Firm is also engaged in the production of specific DNA sequences using the polymerase chain reaction (PCR). It currently has negative earnings. The Company’s product solutions are SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, Sentry, digitalDNA and SmokeCloak DNA.

The stock decreased 4.00% or $0.1 on November 17, hitting $2.4. Applied DNA Sciences Inc (NASDAQ:APDN) has declined 24.05% since April 18, 2016 and is downtrending. It has underperformed by 28.48% the S&P500.

Analysts await Applied DNA Sciences Inc (NASDAQ:APDN) to report earnings on December, 12. They expect $-0.06 EPS, down 200.00% or $0.04 from last year’s $-0.02 per share. After $-0.14 actual EPS reported by Applied DNA Sciences Inc for the previous quarter, Wall Street now forecasts -57.14% EPS growth.

According to Zacks Investment Research, “Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.”

Benchmark Capital Advisors holds 0.39% of its portfolio in Applied DNA Sciences Inc for 150,000 shares. Chase Investment Counsel Corp owns 77,563 shares or 0.11% of their US portfolio. Moreover, Dumont & Blake Investment Advisors Llc has 0.04% invested in the company for 20,921 shares. The Ontario – Canada-based Gluskin Sheff & Assoc Inc has invested 0.01% in the stock. Williams Jones & Associates Llc, a New York-based fund reported 48,990 shares.#img1#

APDN Company Profile

Applied DNA Sciences, Inc., incorporated on December 17, 2008, provides plant deoxyribonucleic acid (DNA) security, and authentication solutions and services that help protect products, brands, supply chains and intellectual property of companies, governments and clients from theft, counterfeiting, fraud and diversion. The Firm is also engaged in the production of specific DNA sequences using the polymerase chain reaction (PCR). The Company’s product solutions are SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, Sentry, digitalDNA and SmokeCloak DNA, among others. The Company’s product solutions are used in various industries, including microcircuits and other electronics, cash-in-transit (transport and storage of banknotes), textiles and apparel, home asset marking, automotive, printing and packaging, homeland security, law enforcement, identity cards and other secure documents, industrial materials, agrochemicals, pharmaceuticals, consumer products, food and beverage, fine wine, and art and collectibles.

More notable recent Applied DNA Sciences Inc (NASDAQ:APDN) news were published by: Reuters.com which released: “BRIEF-Applied DNA Sciences signs reseller agreement with Action-Pak” on November 17, 2016, also Marketwired.com with their article: “Applied DNA Sciences Signs Reseller Agreement with Action-Pak, Inc.” published on November 17, 2016, Marketwired.com published: “Applied DNA Sciences Awarded Contract by the U.S. Defense Logistics Agency” on November 15, 2016. More interesting news about Applied DNA Sciences Inc (NASDAQ:APDN) were released by: Finance.Yahoo.com and their article: “Applied DNA Sciences Updates Investors on Progress in Cotton Vertical During …” published on November 10, 2016 as well as Marketwatch.com‘s news article titled: “Applied DNA Sciences Announces $8.75 Million Registered Direct Offering” with publication date: November 23, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By kentuckypostne


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>